Affimed Announces Participation at Upcoming Virtual Investor Conferences
March 26 2020 - 7:30AM
Heidelberg, Germany, March 26, 2020
– Affimed N.V. (Nasdaq: AFMD), a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer, today announced that the company
will participate in the following upcoming virtual investor
conferences.
- Dr. Adi Hoess, Chief Executive Officer, will present at the
Solebury Trout Virtual Global Healthcare Conference Series on
Thursday, April 2, 2020 at 9:30 a.m. Eastern Time. The presentation
will be webcast live and available for replay in the investor
relations section of Affimed’s website at
https://www.affimed.com/investors/webcasts_cp/.
- Dr. Adi Hoess will conduct virtual one-on-one meetings with
institutional investors at the 2020 Wells Fargo Biotech Corporate
Access Day on Tuesday, April 7, 2020.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer. Affimed’s fit-for-purpose ROCK®
platform allows innate cell engagers to be designed for specific
patient populations. The Company is developing single and
combination therapies to treat hematologic and solid tumors. For
more information, please visit www.affimed.com.
Affimed Investor and Media
Contacts
Gregory Gin, Head of Investor RelationsE-Mail:
IR@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024